From: Head of bed elevation to relieve gastroesophageal reflux symptoms: a systematic review
Studies | Patient-reported gastroesophageal reflux symptoms | Intra-oesophageal pH measurement | Preferences | Adverse events |
---|---|---|---|---|
Morales, 2020, Columbia cross-over RCT [29] | Outcome measures (validated) Reflux Disease Questionnaire Score, a 6-point score, with a higher score meaning a worse outcome and a change of ≥0.6 points considered clinically meaningful Findings (improved) Mean difference (MD) in change scores at 6 weeks of 1.327, 95% CI 0.626 to 2.027. 27 of 39 [69.2%] participants in the head-of-bed elevation group were more likely to report a clinically meaningful change of ≥10% in their symptom scores at 6 weeks compared to 13 [33.3%] in the control group. Risk ratio (RR) of 2.08; 95% CI 1.19 to 3.61). | NR | 63.2% (95% CI 50.6 to 75.7%) of the 57 participants preferred the head of bed elevation to control. | 39 of 63 participants in head-of-bed elevation group reported adverse events at 14 weeks compared to none on the control group (of 54): 20 bed slipping; 4 bed unsteadiness; 10 varicose vain pain; 7 musculoskeletal pain; and 1 sexual activity interference and headache each. |
Huang, 2019, Taiwan, cross-over RCT [28] | Outcome measures (validated) Modified Dysfunction after Upper Gastrointestinal Surgery, a 30-point score, with higher scores means better outcomes. Findings (improved) MD in change scores at 2 weeks − 5.1, 95% CI − 7.6 to − 2.6 | NR | NR | NR |
Hamilton, 1988, United States, cross-over RCT [27] | NR | Outcome measures Acid exposure, defined as percent of total time intra-oesophageal pH remained ≤4; Reflux episodes, defined as drop of intra-oesophageal pH to < 4; Acid clearance time, defined as the total time that intra-oesophageal pH < 4 by the number of reflux episodes. Findings (improved) A reduction in acid exposure in both sleeping on a wedge (mean% 14.8, 95% CI 12.2 to 17.5 vs control: 21.2, 95% CI 18.4 to 23.7) and head-of-bed elevation groups (mean% 15.3, 95% CI 11.7 to 18.8 vs control: 21.2, 95% CI 18.4 to 23.7) compared to the control. A non-statistically significant reduction in the number of reflux episodes and acid clearance time in any of the two groups compared to the control. | 60% (9 of 15) preferred head-of-bed elevation, 33.3% (5 of 15) preferred sleeping on wedge, and 6.7% (1 of 15) preferred neither. | NR |
Harvey, 1987, United Kingdom, factorial RCT [26] | Outcome measures An overall improvement in symptoms and a 4-point-sclae of gastroesophageal reflux, retrosternal pain, epigastric pain, and dysphagia. Findings (improved) 23 of 32 [71.9%] participants in the head-of-bed elevation group are more likely to report an overall improvement in symptoms at 6 weeks compared to 17 of 31 [54.8%] - unadjusted OR 2.1, 95% CI 0.74 to 5.99; adjusted OR 3.1, X2 = 4, p < 0.005. A statistically significant reduction in symptom scores of gastroesophageal reflux and retrosternal pain but not epigastric pain and dysphagia. | NR | NR | 2 of 32 participants in the head-of-bed elevation group reported adverse events both resolved and neither discontinued: 1 bed slipping and 1 sexual activity interference. |
Stanciu, 1977, United Kingdom, cross-over trial [25] | Outcome measures Number of reflux symptoms (i.e. heartburn or acid regurgitation) Findings (improved) Compared to control group, a statistically significant reduction in the number of reflux symptoms during the intervention (6 h) in the head-of-bed elevation group (2.0 ± 1.2 vs. 3.0 ± 2.4) and sleeping on a wedge groups (2.4 ± 1.4 vs. 3.4 ± 2.2). | Outcome measures Acid exposure, defined as percent of total time that intra-esophageal pH remained < 4; Reflux episodes, defined as a drop in intra-esophageal pH by 2; Acid clearance time, defined as the total duration of reflux by the number of reflux episodes. Findings (improved) A statistically significant reductions in acid exposure and reflux episodes in the head-of-bed elevation group (acid exposure: 6.7 ± 7.6; reflux episodes per participant: 3.7 ± 1.9) compared to control group (acid exposure: 14.0 ± 15.3; reflux episodes per participant: 6.2 ± 3.9) but no significant difference in sleeping on a wedge group compared to control group in terms of acid exposure (7.7 ± 11.7 vs 8.9 ± 9.7) and reflux episodes (5.4 ± 3.8 vs. 4.8 ± 3.2). | NR | NR |